Osimertinib Improves Survival in Lung Cancer - NCI
https://www.cancer.gov/news-events/cancer-currents-blog/2023/osimertinib-lung-cancer-adaura
WEBJul 5, 2023 · Home. News & Events. Cancer Currents Blog. Lung Cancer Trial of Osimertinib Draws Praise—and Some Criticism. Subscribe. July 5, 2023 , by Carmen Phillips. Results from the ADAURA trial are expected to have an impact on the treatment of early-stage lung cancer, including people with stage IB disease. Credit: © Terese Winslow.
DA: 79 PA: 42 MOZ Rank: 85